Education Program in Reproduction and Development (EPRD), Department of Obstetrics and Gynaecology, Monash University, Clayton, Melbourne Victoria, Australia.
Education Program in Reproduction and Development (EPRD), Department of Obstetrics and Gynaecology, Monash University, Clayton, Melbourne Victoria, Australia.
Reprod Biomed Online. 2022 Apr;44(4):755-763. doi: 10.1016/j.rbmo.2021.12.016. Epub 2021 Dec 28.
What is the impact of the response to COVID-19 on the management of fertility treatments and clinical practice around the world?
Fertility clinic associates around the world were approached. They completed an online survey containing 33 questions focused on the country's response to the COVID-19 pandemic. Known fertility clinic associates that were contacted comprised scientific directors, medical directors and laboratory managers.
There were 43 individual country responses from Asia (13), Africa (3), Europe (17), North America (3), Oceania (2) and South America (5). In nine countries, clinics followed their government body recommendations, in 22 countries there was a combination of recommendations, in 3 countries changes were made by clinic initiative, and 9 countries did not specify. In 34 countries IVF/intracytoplasmic sperm injection (ICSI) and frozen embryo transfer (FET) treatments had an average delay of 56 days (IVF/ICSI) (minimum 0, maximum 160) and 57 days (FET) (minimum 0, maximum 166 days). During the shutdown, the number of freeze-all cycles increased in 22 countries. Only 23 countries reported patients having to undergo a SARS-CoV-2 test, and 20 countries did not report any COVID-19 testing in their clinic. Additional support counselling was offered in 28 countries, partner restrictions at clinics were reported in 41 countries and time between patients' appointments was increased in 39 countries.
The implications of COVID-19 mitigation measures proved the need for government societies to introduce a set protocol that includes requirements such as increased patient counselling and additional guidelines for prioritizing couples who need care most urgently.
COVID-19 应对措施对全球各地的生育治疗管理和临床实践有何影响？
联系了世界各地的生育诊所。他们完成了一项包含 33 个问题的在线调查，重点关注各国对 COVID-19 大流行的应对措施。联系的已知生育诊所联系人包括科学主任、医学主任和实验室经理。
来自亚洲（13 个）、非洲（3 个）、欧洲（17 个）、北美（3 个）、大洋洲（2 个）和南美（5 个）的 43 个国家做出了单独的回应。在 9 个国家，诊所遵循政府机构的建议；在 22 个国家，建议是组合式的；在 3 个国家，变化是由诊所主动提出的；9 个国家未具体说明。在 34 个国家，体外受精/胞浆内单精子注射（ICSI）和冷冻胚胎移植（FET）治疗平均延迟 56 天（IVF/ICSI）（最短 0，最长 160）和 57 天（FET）（最短 0，最长 166 天）。在关闭期间，22 个国家的冷冻全部周期数量增加。只有 23 个国家报告患者必须进行 SARS-CoV-2 检测，20 个国家未报告在其诊所进行任何 COVID-19 检测。28 个国家提供了额外的支持咨询，41 个国家报告了诊所对伴侣的限制，39 个国家增加了患者预约之间的时间。
COVID-19 缓解措施的影响证明，政府和社会需要引入一套包括增加患者咨询和为最急需护理的夫妇制定额外优先排序指南等要求的协议。
